Alnylam Pharmaceuticals Basic EPS 2010-2025 | ALNY

Alnylam Pharmaceuticals basic eps for the twelve months ending March 31, 2025 was $-2.10, a 20.45% decline year-over-year.

  • Alnylam Pharmaceuticals annual basic eps for 2024 was $-0.002B, a 38.07% decline from 2023.
  • Alnylam Pharmaceuticals annual basic eps for 2023 was $-0.004B, a 62.15% decline from 2022.
  • Alnylam Pharmaceuticals annual basic eps for 2022 was $-0.009B, a 29.17% increase from 2021.

Alnylam Pharmaceuticals Basic EPS 2010-2025 | ALNY

  • Alnylam Pharmaceuticals annual basic eps for 2024 was $-0.002B, a 38.07% decline from 2023.
  • Alnylam Pharmaceuticals annual basic eps for 2023 was $-0.004B, a 62.15% decline from 2022.
  • Alnylam Pharmaceuticals annual basic eps for 2022 was $-0.009B, a 29.17% increase from 2021.